The sky has yet to brighten, but we feel chipper enough to get an early start, as usual. This promises to be a busy day for those who are curious about what Bristol-Myers Squibb ceo Jim Cornelius will say about cutting costs and the like. Of course, there are always a variety of developments to track - for instance,
Pfizer's Chantix is blamed for another suicide (see below). So grab a cup of coffee because here are a few...
Family Blames Chantix For Man's Suicide (The Telegraph)
Sanofi-Aventis Will Keep R&D Spending At Currrent Levels (PharmaTimes)
Wyeth Says Glaxo Rival Won't Derail Prevnar (Reuters)
Novartis Plans Four New Cancer Drugs (The Wall Street Journal)
Japan's Health Ministry Plans Generic Incentives (Bloomberg News)